Abstract:OBJECTIVE:To prepare the monoclonal antibodies (mAbs) against human carbohydrate antigen 15-3 (CA15-3) and establish a double-antibody sandwich chemiluminescent immunoassay (CLIA) system for detecting CA15-3 in the human serum.METHODS:BALB/c mice were immunized with human CA15-3 antigen. Spleen cells of the immunized mice were fused with Sp2/0 cells and the positive hybridoma cells were selected and subcloned. The supernatant was taken for purify mAbs using protein A chromatography. The purity, titer, epitope and subtype of the mAbs were characterized and the sandwich CLIA system was established. The system was evaluated in its accuracy, limit of detection, linearity, repetitiveness and specificity.RESULTS:Five hybridoma cell lines named #3-1-3, #5-2-2, #11-2-2, #12-1-3 and #16-1-3 were obtained respectively, which are of strong positive signal and high secretion. The titers of the mAbs secreted by these hydridomas were above 10(-8); g/mL. All of the mAbs expressed κ light chains, and their heavy chains were as follows: #3-1-3 mAb had IgG2a, #5-2-2 mAb and #12-1-3 mAb had IgG2b, #11-2-2 mAb and #16-1-3 mAb had IgG3. The double-antibody sandwich CLIA system had a good linear relationship between 0.59 U/mL and 300 U/mL. The recovery rate for accuracy was 97.45% and the limit of detection was 0.59 U/mL. The assay was highly linear (correlation coefficient 0.9978) and highly repeatable [coefficient of variation (CV) <10%]. This CLIA system was also highly specific without cross-reactivity to the tumor marker AFP, CEA, CA50, CA19-9 and CA72-4.CONCLUSION:The mAbs against human CA15-3 have been prepared and a sandwich CLIA system for detecting CA15-3 in the human serum has been established successfully, which provides a basis for CA15-3 quantification and clinical application.

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Preparation and Identification of Monoclonal Antibody Against Human Cervical Cancer Oncogene

Recombinant protein expression and monoclonal antibody preparation of HCCR

Preparation, Characterization and Application of Anti-HCCR Monoclonal Antibody

[Protein Expression, Purification of PCGF1 and Its Monoclonal Antibody Preparation and Identification].

Prokaryote Expression of GPC3 C Terminal Protein and Prepration of Monoclonal Antibody

Cloning, expression and purification of gene encoding human hepatocellular carcinoma-associated antigens 661 in E.coli

Preparation and Characterization of the Monoclonal Antibody Against HSPC238 Antigen

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides

Monoclonal Antibody Preparation and Expression Profile Analysis of A Novel Hepatoma Associated Gene

[Preparation and Characterization of the Monoclonal Antibodies Against Human CA15-3 and Establishment of a Sandwich CLIA System].

Preparation and identification of monoclonal antibodies against human prostate stem cell antigen

[Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR: a new biomarker for hepatocellular carcinoma].

Expression of human heparanase protein and production of monoclonal antibodies against human heparanase

Characterization of Monoclonal Antibody CL58 Against Carcinoembryonic Antigen (CEA) and Study of Its Biodistribution

[Expression of GST-HAI-1 Fusion Protein and Development of Monoclonal Antibody Against Human Hepatocyte Growth Factor Activator Inhibitor 1].

Preparing and identifying a monoclonal antibody against human colorectal carcinoma

Expression of 5T4 extracellular domain fusion protein and preparation of anti-5T4 monoclonal antibody with high affinity and internalization efficiency.

[Expression of Human Aspartyl Beta-Hydroxylase and Preparation of Its Monoclonal Antibody].

[Expression, Purification and Activity Analysis of Human Single-Chain Antibody Against Hepatocellular Cancer].

Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential.